Liuyi Lu

569 total citations · 1 hit paper
16 papers, 376 citations indexed

About

Liuyi Lu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Liuyi Lu has authored 16 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Liuyi Lu's work include ATP Synthase and ATPases Research (3 papers), interferon and immune responses (2 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Liuyi Lu is often cited by papers focused on ATP Synthase and ATPases Research (3 papers), interferon and immune responses (2 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Liuyi Lu collaborates with scholars based in China, United States and France. Liuyi Lu's co-authors include Peijie Zheng, Yuemin Ding, Bin Liu, Shiwei Duan, Feng Zhu, Junmeng Zheng, Wenliang Chen, Feng Wei, Jie Liu and Jianwen Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Plant Science.

In The Last Decade

Liuyi Lu

15 papers receiving 370 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy

2022 210 citations Peijie Zheng, Liuyi Lu et al. Journal of Experimental & Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liuyi Lu China	8	143	88	86	74	53	16	376
Dipankar Ash United States	9	159 1.1×	108 1.2×	54 0.6×	69 0.9×	69 1.3×	12	424
Terri Phua Singapore	7	183 1.3×	62 0.7×	83 1.0×	23 0.3×	65 1.2×	7	339
Krishna Priya Mani India	12	90 0.6×	49 0.6×	28 0.3×	37 0.5×	24 0.5×	16	319
Mayu Sun China	10	177 1.2×	22 0.3×	70 0.8×	39 0.5×	79 1.5×	12	403
Yichen Li United States	7	183 1.3×	20 0.2×	53 0.6×	57 0.8×	40 0.8×	12	346
Zhipeng Sun China	10	160 1.1×	46 0.5×	73 0.8×	48 0.6×	18 0.3×	15	334
Jianyu Zhu China	13	179 1.3×	136 1.5×	62 0.7×	26 0.4×	38 0.7×	44	501
Pei‐Ru Wu Taiwan	10	249 1.7×	19 0.2×	82 1.0×	60 0.8×	76 1.4×	17	473
Ren Zhao China	11	296 2.1×	32 0.4×	181 2.1×	225 3.0×	54 1.0×	26	528
Tengku Ahmad Damitri Al‐Astani Tengku Din Malaysia	10	131 0.9×	32 0.4×	88 1.0×	37 0.5×	92 1.7×	28	323

Countries citing papers authored by Liuyi Lu

Since Specialization

Citations

This map shows the geographic impact of Liuyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liuyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liuyi Lu more than expected).

Fields of papers citing papers by Liuyi Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liuyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liuyi Lu. The network helps show where Liuyi Lu may publish in the future.

Co-authorship network of co-authors of Liuyi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Liuyi Lu. A scholar is included among the top collaborators of Liuyi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liuyi Lu. Liuyi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lin, Qingyuan, et al.. (2025). The promising role of nanopore sequencing in cancer diagnostics and treatment. PubMed. 4(2). 100229–100229. 3 indexed citations

Zhang, He, Liuyi Lu, Xu Yang, et al.. (2024). LysM protein BdLM1 of Botryosphaeria dothidea plays an important role in full virulence and inhibits plant immunity by binding chitin and protecting hyphae from hydrolysis. Frontiers in Plant Science. 14. 1320980–1320980. 6 indexed citations

Zhang, Yi, et al.. (2024). Identification and validation of ATP6V1G1-regulated phosphorylated proteins in hepatocellular carcinoma. PLoS ONE. 19(12). e0310037–e0310037. 1 indexed citations

Wang, Chao, et al.. (2024). The efficacy of different types of cerebral embolic protection device during transcatheter aortic valve implantation: a meta-analysis. Frontiers in Cardiovascular Medicine. 11. 1205943–1205943. 1 indexed citations

Guo, Haiyang, et al.. (2024). Unveiling esophageal cancer treatment mechanisms: network pharmacology and molecular docking of Physcion. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(1). 557–568. 1 indexed citations

Zheng, Peijie, et al.. (2023). Nanopore sequencing technology and its applications. SHILAP Revista de lepidopterología. 4(4). e316–e316. 33 indexed citations

Yang, Chao, Liuyi Lu, Liang Shi, et al.. (2023). Inhibition of hexokinase 2 with 3-BrPA promotes MDSCs differentiation and immunosuppressive function. Cellular Immunology. 385. 104688–104688. 8 indexed citations

Gao, Jing‐Wei, Qing-Yun Hao, Liuyi Lu, et al.. (2022). Associations of long-term physical activity trajectories with coronary artery calcium progression and cardiovascular disease events: results from the CARDIA study. British Journal of Sports Medicine. 56(15). 854–861. 16 indexed citations

Zheng, Peijie, et al.. (2022). Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. Journal of Experimental & Clinical Cancer Research. 41(1). 271–271. 210 indexed citations breakdown →

10.

Fu, Yuan, Junxiong Qiu, Jianhua Wu, et al.. (2022). USP14-mediated NLRC5 upregulation inhibits endothelial cell activation and inflammation in atherosclerosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868(5). 159258–159258. 11 indexed citations

11.

Lu, Liuyi, Junxiong Qiu, Chao Wang, et al.. (2022). ZBTB20 regulates cardiac allograft rejection through NFкB-mediated inflammation in mouse heart transplantation. Transplant Immunology. 74. 101676–101676. 5 indexed citations

12.

Chen, Mingxing, et al.. (2021). Performance evaluation between two automated biochemical analyzer systems: Roche Cobas 8000 and Mindray BS2000M. Journal of Medical Biochemistry. 41(3). 306–315. 3 indexed citations

13.

Tao, Jun, Junxiong Qiu, Liuyi Lu, et al.. (2021). ZBTB20 Positively Regulates Oxidative Stress, Mitochondrial Fission, and Inflammatory Responses of ox‐LDL‐Induced Macrophages in Atherosclerosis. Oxidative Medicine and Cellular Longevity. 2021(1). 5590855–5590855. 19 indexed citations

14.

Lu, Liuyi, Huanji Zhang, Ming Gao, et al.. (2020). Warfarin Accelerates Aortic Calcification by Upregulating Senescence-Associated Secretory Phenotype Maker Expression. Oxidative Medicine and Cellular Longevity. 2020. 1–13. 7 indexed citations

15.

Li, Xiaoxue, Liuyi Lu, Jie Chen, et al.. (2019). New Insight into the Mechanisms of Ginkgo Biloba Extract in Vascular Aging Prevention. Current Vascular Pharmacology. 18(4). 334–345. 12 indexed citations

16.

Lu, Liuyi, Mei Li, Hong‐Shuo Sun, et al.. (2017). Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway. Acta Pharmacologica Sinica. 38(9). 1236–1247. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact